| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,671 | 17,133 | 16,934 | 17,064 | | Cost of Revenue |
-
| (2,111) | 2,111 | 1,084 | | | Gross Profit |
-
| 19,244 | 14,823 | 15,980 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,785 | 10,449 | 10,438 | 11,881 | | Non Recurring |
-
|
-
|
-
| (1,062) | | Others | 1,363 | 2,293 | 1,457 | 1,582 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 6,502 | 2,928 | 3,579 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,039) | 6,567 | 2,863 | 3,444 | | Interest Expense | (3,900) | 3,900 |
-
| 1,723 | | Income Before Tax | 2,861 | 2,667 | 2,863 | 1,721 | | Income Tax Expense | 810 | 681 | 827 | 775 | | Minority Interest | (102) | (190) |
-
| (99) | | | | Net Income From Continuing Ops | 3,840 | 1,796 | 2,036 | 946 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,949 | 1,796 | 2,036 | 946 | | Preferred Stock And Other Adjustments |
-
| 81 | (81) |
-
| | | Net Income Applicable To Common Shares | $1,949 | $1,877 | $1,955 | $946 |
|
0.51% Nasdaq 
Income Statement
